Introduction: In recent years, the presence of non-communicable diseases, particularly hypertension (HTN), obesity, and type 2 diabetes mellitus (T2DM), has emerged as a significant threat to global public health. Objective: To determine the trends and factors associated with these diseases' isolated and combined presence in both dual and triple forms (metabolic triad). Methods: Secondary data analysis from the Demographic and Family Health Survey for 2014 to 2022. The primary variable had seven categories, ranging from isolated states to triple combinations. Given the polytomous nature of the dependent variable, multinomial logistic regression models were constructed. The results of these models are presented in the form of adjusted odds ratios, accompanied by their 95% confidence intervals (95% CI). Results: Among the isolated forms, obesity was the most prevalent comorbidity (15.35%), while T2DM was the least common (1.14%). Among the combined forms, the most frequent was obesity and HTN (6.40%). The prevalence of the metabolic triad was low (0.84%). The factors commonly related to each were female sex, age, urban residency, region, economic level, daily smoking, alcohol consumption, and altitude. Conclusions: An increasing prevalence of HTN, T2DM, and obesity was found, both individually and in their various combinations. Furthermore, the complexity and sometimes contradictory nature of the associated factors, which can increase or decrease the presence of these metabolic diseases, reflect the need for a personalized approach to prevention and treatment.

The authors have declared no competing interest.

This study did not receive any funding

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The data supporting the findings of this study can be accessed at the following link: https://proyectos.inei.gob.pe/microdatos/

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes